This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Alfred Von Krempelhuber
Medical Director at Moderna Germany GmbH

Profile

Dr. Alfred von Krempelhuber acts as Medical Director at Moderna Germany GmbH. Since the beginning of March 2022, he has held this position at the new local subsidiary of the US mRNA specialist. Von Krempelhuber has more than 20 years of experience in clinical development and medicine in various management roles. Holding a doctorate in biology, he comes from the British pharmaceutical company GlaxoSmithKline, where he held various positions in the field of vaccines for more than ten years, most recently as Head of Scientific Communication Vaccines. Previously, von Krempelhuber led the clinical development of a new smallpox vaccine at Bavarian Nordic.

Agenda Sessions

  • mRNA vaccines: Can they Fulfill the Promise?

    13:45